OMX30 1 591 1,4%  OMXH25 3 761 1,2%  OMXC20 918 0,7%  Dow 21 152 1,6%  Nas 5 393 1,2%  EUR 9,5382 -0,2%  USD 9,0380 -0,1%  Olja 56,4 1,6%  Guld 1 249 0,1% 

Pfizer Aktie

312,00SEK 4,50SEK 1,46%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Pfizer

2016 2017e 2018e 2019e 2020e
Utdelning 1,20 1,28 1,47 1,44 1,52
Direktavkastning (i %) 3,69 3,76 4,33 4,23 4,48
PE-tal 13,54 13,24 12,20 11,82 11,17
Resultat/aktie 2,40 2,57 2,79 2,87 3,04
ytterligare nyheter

Analyser om Pfizer Inc.

Feb, 17 2017 Pfizer Hold Jefferies & Company Inc.
Feb, 17 2017 Pfizer Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
Feb, 02 2017 Pfizer Buy Morningstar
Feb, 01 2017 Pfizer Buy Atlantic Equities
Jan, 24 2017 Pfizer Outperform Bernstein Research
ytterligare analyser

Pfizer Peer Group

Abbott Laboratories 45,65
1,3%
Alexion Pharmaceuticals 134,08
2,2%
AstraZeneca 527,00
-0,3%
Bayer 105,60
1,7%
Celgene 123,89
0,3%
EVOTEC 7,38
1,2%
Gilead Sciences 70,23
-0,3%
GlaxoSmithKline 16,67
1,1%
Johnson & Johnson 123,79
1,3%
Merck 66,30
0,6%
Merck 104,20
1,0%
MorphoSys 55,57
3,3%
Mylan 44,80
7,0%
Novartis 78,75
0,4%
Pfizer 34,47
1,0%
Roche 248,00
0,6%
STADA Arzneimittel 57,20
0,1%
Sanofi 82,82
1,8%
Teva Pharmaceutical Industries 34,95
-0,2%
Vertex Pharmaceuticals 90,07
-0,6%
pagehit

Lägg till instrument

Vad tycker du?

Profil Pfizer Inc.

till bolagsprofilen
Pfizer, Inc. is a research-based, global biopharmaceutical company, which engages in the manufacture of vaccines and injectable biologic medicines. It operates through the following segments: Global Innovative Pharmaceutical, Global Vaccines, Oncology and Consumer Healthcare, and Global Established Pharmaceutical. The Global Innovative Pharmaceutical segment focuses on developing, registering and commercializing novel, value creating medicines that significantly improve patients lives. The Global Vaccines, Oncology and Consumer Healthcare segment engages in the development and commercialization of vaccines and products for oncology and consumer healthcare. The Global Established Pharmaceutical segment includes the brands that have lost market exclusivity and, generally, the mature, patent-protected products that are expected to lose exclusivity through 2015 in most major markets and, to a much smaller extent, generic pharmaceuticals. The company was founded by Charles Pfizer Sr. and Charles H. Erhart Jr. in 1849 and is headquartered in New York, NY.

Realtidskurs Pfizer Inc.

Bid
34,47
USD
Ask
34,47
USD
Kurstid
21:27
Börsen BTT

Aktiekurs Pfizer Inc. i SEKPUSH CHART

Kurs 312,00 SEK 4,50 1,46 %
Kurstid 17:29:43
Datum 01.03.2017
Öppning 308,00
Gårdagen 307,50
Dagshögsta 312,00
Dagslägsta 307,50
52 v. högsta 320,00
52 v. lägsta 235,00
52 v. perf.
Volym (Antal) 3 395
Börsvärde (SEK) 1 821,63 Mrd
Börsen

Till aktien Pfizer

Ticker PFE
ISIN US7170811035
Index Dow Jones, S&P 500, S&P 100, NYSE US 100, BX Swiss - USA

Struktuerarde produkter på Pfizer

Produkttyp Antal
Mini Futures 3

Pfizer Nyckeltal

Börsvärde i SEK 1 821,63 Mrd
Free float % 99,94
Antal aktier mio. 5 951,87
Cashflow/aktie i lokal valuta 2,07
Bokvärde/aktie i lokal valuta 9,84
60 dagar vola 18,97
PBV 3,30

Pfizer Historiska kurser

2017-02-28 307,50 6 837
2017-02-27 308,50 2 503
2017-02-24 308,50 2 869
2017-02-23 303,50 2 981
2017-02-22 301,00 4 030

Aktier i samma industri med bättre 1 års perf.

Exelixis Inc. 478,8 %
SIGA Technologies Inc. 466,0 %
Array BioPharma Inc. 336,9 %
EXACT Sciences Corp. 301,6 %
Amylin Pharmaceuticals Inc. 264,9 %